Publication | Closed Access
Recurrent Clostridium difficile Infection in a Patient with Selective IgG1 Deficiency Treated with Intravenous Immune Globulin and Saccharomyces boulardii
49
Citations
0
References
1995
Year
Clinical ImmunologyImmunohematologySaccharomyces BoulardiiMicrobial PathogensImmunodeficienciesImmunologyImmune RegulationLynne McfarlandImmune SystemImmunotherapyIntravenous Immune GlobulinInfection ControlHealth SciencesPrimary ImmunodeficiencyAutoimmune DiseaseJoseph HassettHumoral ImmunityImmunologic DiseaseImmune FunctionClinical MicrobiologyInborn Error Of ImmunityMolecular Diagnostic TechniquesPathogenesisImmunoglobulin EMedicine
Journal Article Recurrent Clostridium difficile Infection in a Patient with Selective IgG1 Deficiency Treated with Intravenous Immune Globulin and Saccharomyces boulardii Get access Joseph Hassett, Joseph Hassett From the Department of Medicine, Divisions of Clinical Immunology and Gastroenterology, Mount Sinai Medical Center, New York, New York; the Department of Medicinal Chemistry, University of Washington and Biocodex, Inc., Seattle, Washington; and the Department of Medicine, Infectious Diseases Division, Veterans Affairs Medical Center, Long Beach, and the University of California, Irvine, School of Medicine, Irvine, California Reprints or correspondence: Dr. Joseph M. Hassett, Mount Sinai School of Medicine, Department of Medicine, Division of Clinical Immunology, Box 1089, Annenberg 23-201, New York, New York 10029-6574. Search for other works by this author on: Oxford Academic PubMed Google Scholar Samuel Meyers, Samuel Meyers From the Department of Medicine, Divisions of Clinical Immunology and Gastroenterology, Mount Sinai Medical Center, New York, New York; the Department of Medicinal Chemistry, University of Washington and Biocodex, Inc., Seattle, Washington; and the Department of Medicine, Infectious Diseases Division, Veterans Affairs Medical Center, Long Beach, and the University of California, Irvine, School of Medicine, Irvine, California Search for other works by this author on: Oxford Academic PubMed Google Scholar Lynne McFarland, Lynne McFarland From the Department of Medicine, Divisions of Clinical Immunology and Gastroenterology, Mount Sinai Medical Center, New York, New York; the Department of Medicinal Chemistry, University of Washington and Biocodex, Inc., Seattle, Washington; and the Department of Medicine, Infectious Diseases Division, Veterans Affairs Medical Center, Long Beach, and the University of California, Irvine, School of Medicine, Irvine, California Search for other works by this author on: Oxford Academic PubMed Google Scholar Maury Ellis Mulligan Maury Ellis Mulligan From the Department of Medicine, Divisions of Clinical Immunology and Gastroenterology, Mount Sinai Medical Center, New York, New York; the Department of Medicinal Chemistry, University of Washington and Biocodex, Inc., Seattle, Washington; and the Department of Medicine, Infectious Diseases Division, Veterans Affairs Medical Center, Long Beach, and the University of California, Irvine, School of Medicine, Irvine, California Search for other works by this author on: Oxford Academic PubMed Google Scholar Clinical Infectious Diseases, Volume 20, Issue Supplement_2, June 1995, Pages S266–S268, https://doi.org/10.1093/clinids/20.Supplement_2.S266 Published: 01 June 1995